VivoSeq
Cardiovascular

Hypotensive Anesthesia

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Hypotensive Anesthesia is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed6 · 43%
Recruiting3 · 21%
Unknown status2 · 14%
Enrolling by invitation1 · 7%
Active, not recruiting1 · 7%
Suspended1 · 7%

Trial Activity

14 trials

Labetalol Infusion and Dexmedetomidine Infusion in Hypotensive Anesthesia
Recruiting··Phase 4·NCT06752863·80 enrolled
Hypotensive Anesthesia for Orthognathic Surgery
Active, not recruiting··Phase 4·NCT06093893·90 enrolled
Effect of Hypotensive Anesthesia on the Perfusion Index
Completed··Phase 1·NCT03059316·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)